Mast Cells in Irritable Bowel Syndrome: A Systematic Review

被引:31
|
作者
Krammer, Luisa [1 ]
Sowa, Anna Sergeevna [1 ]
Lorentz, Axel [1 ]
机构
[1] Univ Hohenheim, Inst Nutr Med, Stuttgart, Germany
关键词
mast cells; irritable bowel syndrome; functional gastrointestinal disorder; visceral hypersensitivity; MUCOSAL IMMUNE-SYSTEM; QUALITY-OF-LIFE; VISCERAL HYPERSENSITIVITY; ENTEROCHROMAFFIN CELL; BARRIER FUNCTION; DIARRHEA; ACTIVATION; EXPRESSION; IMPACT; INFLAMMATION;
D O I
10.15403/jgld-229
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
Background & Aims: As mast cells (MC) serve as a link between mucosal immune activity and the nervous system, it is likely they also play a role in the pathogenesis of irritable bowel syndrome (IBS). This connection might be an important factor in the development of IBS-related symptoms. Method: This overview comprises 36 case-control studies published from 2000 to 2018 that investigated MC in bowel biopsies of IBS patients and controls. 'I he studies were selected from PubMed, EMBASE, Central, SemanticScholar by an electronic search, performed using RISMed R package. Results: Significantly increased mucosal MC counts/or density in IBS patients compared to controls was observed in 30 studies. Five studies reported no differences and only one of the studies found a decreased amount of MC in an IBS patient. Furthermore, 15 studies made a statement regarding the correlation between the amount of MC and IBS associated symptoms. A significant positive correlation between MC count and IBS-associated symptoms was found in six investigations. A negative correlation was not reported. Conclusion: The results support the idea that MC are involved in IBS pathophysiology as key players in the interplay between psychological factors and the frequency and severity of IBS symptoms.
引用
收藏
页码:463 / +
页数:11
相关论文
共 50 条
  • [1] Increased mast cells in the irritable bowel syndrome
    O'Sullivan, M
    Clayton, N
    Breslin, NP
    Harman, I
    Bountra, C
    McLaren, A
    O'Morain, CA
    NEUROGASTROENTEROLOGY AND MOTILITY, 2000, 12 (05): : 449 - 457
  • [2] Colonic mast cells in irritable bowel syndrome
    Park, CH
    Joo, YE
    Choi, SK
    Rew, JS
    Kim, SJ
    Lee, MC
    GASTROENTEROLOGY, 2002, 122 (04) : A552 - A552
  • [3] The Role of Mast Cells in Irritable Bowel Syndrome
    Lee, Kang Nyeong
    Lee, Oh Young
    GASTROENTEROLOGY RESEARCH AND PRACTICE, 2016, 2016
  • [4] Irritable Bowel Syndrome and the Elusive Mast Cells
    Theoharides, Theoharis C.
    Asadi, Shahrzad
    Chen, Jihong
    Huizinga, Jan D.
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2012, 107 (05): : 727 - 729
  • [5] Efficacy of mast cell directed therapies in irritable bowel syndrome: a systematic review
    Coppens, D.
    Kips, M.
    Stievenard, T.
    Mertens, C.
    De Schepper, H.
    ACTA GASTRO-ENTEROLOGICA BELGICA, 2024, 87 (01) : 15 - 27
  • [6] Probiotics in irritable bowel syndrome: A systematic review
    Othman, MO
    Roy, PK
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2005, 100 (09): : S332 - S332
  • [7] Antidepressants for irritable bowel syndrome—A systematic review
    Agnieszka Kułak-Bejda
    Grzegorz Bejda
    Napoleon Waszkiewicz
    Pharmacological Reports, 2017, 69 : 1366 - 1379
  • [8] Psychotherapy for Irritable Bowel Syndrome: A Systematic Review
    Slouha, Ethan
    Patel, Bansari
    Mohamed, Ahmed
    Razeq, Ziyad
    Clunes, Lucy A.
    Kollias, Theofanis F.
    CUREUS JOURNAL OF MEDICAL SCIENCE, 2023, 15 (12)
  • [9] Hypnotherapy for Irritable Bowel Syndrome - a Systematic Review
    Hefner, J.
    Rilk, A.
    Herbert, B. M.
    Zipfel, S.
    Enck, P.
    Martens, U.
    ZEITSCHRIFT FUR GASTROENTEROLOGIE, 2009, 47 (11): : 1153 - 1159
  • [10] MicroRNAs in Irritable Bowel Syndrome: a Systematic Review
    Yanai, Katsunori
    Ishibashi, Kenichi
    Morishita, Yoshiyuki
    DISCOVERY MEDICINE, 2022, 34 (171) : 7 - 18